Cellino

📍 Cambridge, United States🗓 Founded 2017👥 81 employees💰 Last funded Jan 2022
Biotechnology Research🌐 cellinobio.com
Website LinkedIn
Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinsons disease.
3
Total investors
0
Early stage
3
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2021–2022 · investors recorded per year
2021220221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cellino?
Cellino has 3 investors on record on gritt.io, 3 mid-stage.
When did Cellino last raise funding?
The most recent investment in Cellino recorded on gritt.io was in January 2022.
When was Cellino founded?
Cellino was founded in 2017.
What industry is Cellino in?
Cellino operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cellino based?
Cellino is headquartered in Cambridge, United States.